CA2156916A1 - Use of 2-chloro-1¬¬4-(2,6-dichlorophenoxy)methyl|-phenyl|methoxy|- 4-methoxy-benzene for the selective treatment of enteroviral infections in humans - Google Patents

Use of 2-chloro-1¬¬4-(2,6-dichlorophenoxy)methyl|-phenyl|methoxy|- 4-methoxy-benzene for the selective treatment of enteroviral infections in humans

Info

Publication number
CA2156916A1
CA2156916A1 CA002156916A CA2156916A CA2156916A1 CA 2156916 A1 CA2156916 A1 CA 2156916A1 CA 002156916 A CA002156916 A CA 002156916A CA 2156916 A CA2156916 A CA 2156916A CA 2156916 A1 CA2156916 A1 CA 2156916A1
Authority
CA
Canada
Prior art keywords
enteroviral
formula
compound
humans
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002156916A
Other languages
English (en)
French (fr)
Inventor
Edward J. Rozhon
John F. O'connell
Peter Buontempo
Stuart A. Cox
Jason L. Demartino
Jacquelyn M. Wright
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp & Dohme LLC
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2156916A1 publication Critical patent/CA2156916A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Epoxy Compounds (AREA)
  • Medicinal Preparation (AREA)
CA002156916A 1993-02-26 1994-02-23 Use of 2-chloro-1¬¬4-(2,6-dichlorophenoxy)methyl|-phenyl|methoxy|- 4-methoxy-benzene for the selective treatment of enteroviral infections in humans Abandoned CA2156916A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2352793A 1993-02-26 1993-02-26
US08/023,527 1993-02-26

Publications (1)

Publication Number Publication Date
CA2156916A1 true CA2156916A1 (en) 1994-09-01

Family

ID=21815649

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002156916A Abandoned CA2156916A1 (en) 1993-02-26 1994-02-23 Use of 2-chloro-1¬¬4-(2,6-dichlorophenoxy)methyl|-phenyl|methoxy|- 4-methoxy-benzene for the selective treatment of enteroviral infections in humans

Country Status (12)

Country Link
EP (1) EP0686032A1 (cg-RX-API-DMAC10.html)
JP (1) JPH08507062A (cg-RX-API-DMAC10.html)
AU (1) AU691490B2 (cg-RX-API-DMAC10.html)
CA (1) CA2156916A1 (cg-RX-API-DMAC10.html)
FI (1) FI953980A7 (cg-RX-API-DMAC10.html)
HU (1) HUT72490A (cg-RX-API-DMAC10.html)
IL (1) IL108749A0 (cg-RX-API-DMAC10.html)
MX (1) MXPA94001379A (cg-RX-API-DMAC10.html)
NZ (1) NZ262794A (cg-RX-API-DMAC10.html)
TW (1) TW284686B (cg-RX-API-DMAC10.html)
WO (1) WO1994018960A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA941244B (cg-RX-API-DMAC10.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020070390A1 (en) 2018-10-03 2020-04-09 Jyväskylän Yliopisto Vemurafenib and salts thereof for use in the treatment of enteroviral infections

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE8412799U1 (de) * 1984-04-26 1984-10-31 William Prym-Werke Kg, 5190 Stolberg SB-Verkaufsvorrichtung mit einer als Blisterpackung ausgebildeten Verkaufspackung fuer Fadenlegewerkzeuge wie Stricknadeln
NZ243180A (en) * 1991-06-19 1995-08-28 Schering Corp Aromatic ether derivatives and antiviral compositions thereof

Also Published As

Publication number Publication date
NZ262794A (en) 1997-03-24
IL108749A0 (en) 1994-05-30
JPH08507062A (ja) 1996-07-30
HUT72490A (en) 1996-05-28
MXPA94001379A (es) 2011-09-26
HU9502494D0 (en) 1995-10-30
FI953980A0 (fi) 1995-08-24
TW284686B (cg-RX-API-DMAC10.html) 1996-09-01
EP0686032A1 (en) 1995-12-13
FI953980L (fi) 1995-08-24
WO1994018960A1 (en) 1994-09-01
ZA941244B (en) 1994-08-23
AU691490B2 (en) 1998-05-21
FI953980A7 (fi) 1995-08-24
AU6267994A (en) 1994-09-14

Similar Documents

Publication Publication Date Title
Bearden et al. Enteroviruses in X-linked agammaglobulinemia: update on epidemiology and therapy
Marker et al. A trial of vidarabine for cytomegalovirus infection in renal transplant patients
Wang et al. In vitro and in vivo efficacy of a novel nucleoside analog H44 against Crimean–Congo hemorrhagic fever virus
Ch'ien et al. Antiviral chemotherapy and neonatal herpes simplex virus infection: a pilot study—experience with adenine arabinoside (ARA-A)
Watson et al. Changes in lymphocyte and macrophage subsets due to morphine and ethanol treatment during a retrovirus infection causing murine AIDS
CN119950474A (zh) 异绿原酸c在制备抗呼吸道合胞病毒a型株药物中的应用
CN114504578A (zh) 治疗、预防由病毒感染引起的相关疾病的药物及其用途
Al-juhaishi et al. Safety and Efficacy of antiviral drugs against covid-19 infection: an updated systemic review
McKinlay et al. Use of WIN 51711 to prevent echovirus type 9-induced paralysis in suckling mice
Grist et al. General pathogenicity and epidemiology
US5519028A (en) Antiviral preparations
AU691490B2 (en) Use of 2-chloro-1-{{4-{(2,6-dichlorophenoxy)methyl}-phenyl}methoxy} -4-methoxy-benzene for the selective treatment of enteroviral infections in humans
CN113332279A (zh) Ganetespib化合物在制备抗EV71病毒药物中的应用
KR20120112707A (ko) 항-에이즈 제제로서 다중고리 화합물의 제약학적 용도
CN118615294A (zh) 一种小分子化合物cl-255及其衍生物在抗rna病毒感染中的应用
Kroon et al. Long-term suppression of severe recurrent genital herpes simplex infections with oral acyclovir: a dose-titration study.
US20230213515A1 (en) Drug and diagnostic combination system to identify and treat single-stranded rna viruses including coronaviruses and monkeypox
Talsma et al. Generalised Coxsackie A9 infection in a neonate presenting with pericarditis.
Mellette et al. Toxic reaction to para-aminosalicylic acid and isoniazid accompanied by leukopenia and atypical lymphocytosis
O'Connell et al. Development of antiviral agents for picornavirus infections
CN113082028B (zh) Alpelisib化合物在制备抗EV71病毒药物中的应用
CN115957222B (zh) Efavirenz在制备抗腺病毒ADV7药物中的应用
Roberton et al. Failure of intraventricular gammaglobulin and alpha interferon for persistent encephalitis in congenital hypogammaglobulinaemia.
Christen et al. Hand-foot-and-mouth disease in a father and son
Hassan Onychomadesis (nail shedding) secondary to enterovirus herpangina like infection and without the skin manifestations of hand foot mouth disease

Legal Events

Date Code Title Description
FZDE Discontinued